Screener
Sabra Healthcare SBRA EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net income | 40,813 | 40,304 |
| Net loss attributable to noncontrolling interests | 67 | — |
| Net income attributable to Sabra Health Care REIT, Inc. | $40,880 | $40,304 |
| Net income attributable to Sabra Health Care REIT, Inc., per: | ||
| Basic common share | $0.16 | $0.17 |
| Diluted common share | $0.16 | $0.17 |
| Weighted average number of common shares outstanding, basic | 252,135,103 | 237,891,035 |
| Weighted average number of common shares outstanding, diluted | 255,965,287 | 240,295,817 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's EPS (diluted)?
- Sabra Healthcare (SBRA) reported EPS (diluted) of $0.16 in Q1 2026.
- How has Sabra Healthcare's EPS (diluted) changed year-over-year?
- Sabra Healthcare's EPS (diluted) decreased by 5.9% year-over-year, from $0.17 to $0.16.
- What is the long-term trend for Sabra Healthcare's EPS (diluted)?
- Over 4 years (2021 to 2025), Sabra Healthcare's EPS (diluted) has grown at a 5.8% compound annual growth rate (CAGR), from -$0.51 to $0.64.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Sabra Healthcare's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude